搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe ATP-dependent RNA helicase dbp8 (dbp8) CSB-YP881053SXV
CSB-EP881053SXV
CSB-BP881053SXV
CSB-MP881053SXV
CSB-EP881053SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe t-SNARE affecting a late Golgi compartment protein 1 (tlg1), partial CSB-YP881054SXV
CSB-EP881054SXV
CSB-BP881054SXV
CSB-MP881054SXV
CSB-EP881054SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Bromodomain-containing protein C631.02 (SPAC631.02), partial CSB-YP881055SXV
CSB-EP881055SXV
CSB-BP881055SXV
CSB-MP881055SXV
CSB-EP881055SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant NADP-specific glutamate dehydrogenase (GDH) CSB-YP881056NCM
CSB-EP881056NCM
CSB-BP881056NCM
CSB-MP881056NCM
CSB-EP881056NCM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant DNA polymerase (pol) CSB-YP881057THAJ
CSB-EP881057THAJ
CSB-BP881057THAJ
CSB-MP881057THAJ
CSB-EP881057THAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L18P (rpl18p) CSB-YP881058FHW
CSB-EP881058FHW
CSB-BP881058FHW
CSB-MP881058FHW
CSB-EP881058FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloferax volcanii Thermosome subunit 3 (cct3), partial CSB-YP881059HTU
CSB-EP881059HTU
CSB-BP881059HTU
CSB-MP881059HTU
CSB-EP881059HTU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Cell division protein FtsZ 3 (ftsZ3) CSB-YP881060FHY
CSB-EP881060FHY
CSB-BP881060FHY
CSB-MP881060FHY
CSB-EP881060FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Arginine/ornithine antiporter ArcD (arcD), partial CSB-YP881061HTM
CSB-EP881061HTM
CSB-BP881061HTM
CSB-MP881061HTM
CSB-EP881061HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Protein gvpD 2 (gvpD2) CSB-YP881062HTM
CSB-EP881062HTM
CSB-BP881062HTM
CSB-MP881062HTM
CSB-EP881062HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Protein gvpI 1 (gvpI11) CSB-YP881063HTM
CSB-EP881063HTM
CSB-BP881063HTM
CSB-MP881063HTM
CSB-EP881063HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Serine hydroxymethyltransferase (glyA) CSB-YP881064TND
CSB-EP881064TND
CSB-BP881064TND
CSB-MP881064TND
CSB-EP881064TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Nascent polypeptide-associated complex protein (nac) CSB-YP881065TND
CSB-EP881065TND
CSB-BP881065TND
CSB-MP881065TND
CSB-EP881065TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Putative HTH-type transcriptional regulatory protein Ta1363 (Ta1363) CSB-YP881066TND
CSB-EP881066TND
CSB-BP881066TND
CSB-MP881066TND
CSB-EP881066TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Ornithine carbamoyltransferase, catabolic (arcB) CSB-YP881067TND
CSB-EP881067TND
CSB-BP881067TND
CSB-MP881067TND
CSB-EP881067TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Replication factor C large subunit (rfcL) CSB-YP881068TND
CSB-EP881068TND
CSB-BP881068TND
CSB-MP881068TND
CSB-EP881068TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum 30S ribosomal protein S19P (rps19p) CSB-YP881069TND
CSB-EP881069TND
CSB-BP881069TND
CSB-MP881069TND
CSB-EP881069TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum 50S ribosomal protein L32e (rpl32e) CSB-YP881070TND
CSB-EP881070TND
CSB-BP881070TND
CSB-MP881070TND
CSB-EP881070TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum 30S ribosomal protein S27e (rps27e) CSB-YP881071TND
CSB-EP881071TND
CSB-BP881071TND
CSB-MP881071TND
CSB-EP881071TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum 30S ribosomal protein S3Ae (rps3Ae) CSB-YP881072TND
CSB-EP881072TND
CSB-BP881072TND
CSB-MP881072TND
CSB-EP881072TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>